We studied the binding of carboxyatractylate (CAT) and bongkrekate (BKA) to the solubilized ATP,ADP carrier-linked binding protein, which had been incorporated into liposomes. After solubilization with 3-lauramido-N,N-dimethylpropylamine oxide the binding protein had largely lost it affinity and binding capacity for both CAT and BKA. On incorporation into phospholipid vesicles, CAT binding was restored to a considerable extent (3.5 mumol of CAT/g of protein), reaching the original affinity as observed in mitochondria (Kd = 10(-8) M). With high amounts of CAT and under the influence of ADP the binding can be increased to 6.8 mumol of CAT/g of protein, indicating a movement of binding sites in the liposomal membrane. The binding of BKA was also reconstituted with high affinity (Kd = 8 X 10(-8) M) and to the same extent (6.4 mumol of BKA/g of protein). As in the case of intact mitochondria, this reconstituted binding depends on the presence of ADP. This dependence on ADP has an apparent Km = 7 muM, similar to the carrier affinity for ADP in intact mitochondria. The reorientation model of Klingenberg for the ADP,ATP carrier implicating an ADP-catalyzed transition between the CAT binding form (c state) and BKA binding form (m state) in the inner mitochondrial membrane has been confirmed in this reconstituted system.
No takes yet. Share an insight, caveat, or question.
Kraemer et al. (1977) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: